The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s pediatric clinical trials market report forecasts the pediatric clinical trials market size to grow to $20.87 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Pediatric Clinical Trials Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report

Pediatric Clinical Trials Market Size Forecast
The global pediatric clinical trials market is expected to grow from $15.39 billion in 2022 to $16.31 billion in 2023 at a compound annual growth rate (CAGR) of 6.00%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pediatric clinical trials market size is expected to reach $20.87 billion in 2027 at a CAGR of 4.81%.

North America held the largest pediatric clinical trials market share.

Key Pediatric Clinical Trials Market Driver ­– Rise In Pediatric Cancer Cases
For example, according to the National Cancer Institute, a US-based organiser of the US National Cancer Programme, in September 2020, In the United States, it is expected that 16,850 children and teens between the ages of 0 and 19 would be diagnosed with cancer in 2020, with 1,730 dying as a result. Furthermore, according to the American Cancer Society, a US-based voluntary health organisation, it is anticipated that around 9,910 children under the age of 15 will be diagnosed with cancer in the United States in 2023, with approximately 1,040 children under the age of 15 dying from cancer. As a result, rising healthcare costs are propelling the paediatric cancer trials market.

Request for A Sample Of The Global Pediatric Clinical Trials Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp

Key Pediatric Clinical Trials Market Trend – Product Innovation
Companies in the paediatric clinical trials market are implementing new creative products to maintain their market position. For example, in June 2022, The Leukaemia & Lymphoma Society, a non-profit health organisation based in the United States, will commence the Paediatric Acute Leukaemia (PedAL) Master Clinical Trial. It is specifically created for paediatric acute leukaemia, with each child’s tumour biology identified to assist match them with the most promising treatment.

Pediatric Clinical Trials Market Segment
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Treatment Studies, Observational Studies
3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas

Pediatric Clinical Trials Market Major Players and Strategies
Major players in the pediatric clinical trials market are Medpac Inc., PPD Inc., ICON PLC., Syneos Health, QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, LabCrop Drug Development, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company and GlaxoSmithKline PLC.

Thermo Fisher Scientific Inc., a US-based maker of medical equipment, analytical instruments, reagents and consumables, software, and services, paid $17.4 billion for PPD, Inc. in December 2021. This acquisition broadens, diversifies, and enriches Thermo’s portfolio by offering a comprehensive suite of world-class clinical trial development services ranging from scientific discovery to evaluating effectiveness, safety, and health care outcomes, managing clinical trial logistics, and developing and manufacturing drug products. PPD, Inc. is a clinical research services supplier to the biopharma and biotech industries situated in the United States that specialises in paediatric clinical studies.

The Pediatric Clinical Trials Global Market Report 2023 covers regional data on pediatric clinical trials market size, pediatric clinical trials market trends and drivers, opportunities, strategies, and pediatric clinical trials market competitor analysis. The countries covered in the pediatric clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Paediatric clinical trials investigate the efficacy, safety, and dosing of medications, medical devices, and other interventions in children. To find and improve the finest medical therapy feasible, age-specific, scientifically established therapies and methods must be developed.

View More Reports Related To The Pediatric Clinical Trials Market –
Pediatric Vaccine Global Market Report 2023
Clinical Oncology Next Generation Sequencing Global Market Report 2023
Pediatric Imaging Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: